financetom
Business
financetom
/
Business
/
What's Going On With Ulta Beauty Shares Friday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Ulta Beauty Shares Friday?
Mar 14, 2025 9:41 AM

Ulta Beauty, Inc. ( ULTA ) stock is trading higher on Friday after the company reported better-than-expected fourth-quarter earnings on Thursday.

The Details: Ulta reported earnings per share of $8.46, beating analysts’ estimate of $7.14. In addition, the company reported sales of $3.49 billion, beating analysts’ estimate of $3.46 billion but falling 1.9% year-over-year.

The company attributed the decline to an extra week of sales in fiscal-year 2023, partially offset by new store openings and higher same-store sales. Comparable sales rose 1.5%, driven by a 3.0% increase in average ticket size, despite a 1.4% drop in transactions.

For fiscal-year 2025, Ulta expects net sales between $11.5 billion and $11.6 billion, versus analysts’ estimate of $11.67 billion. The company projects earnings per share between $22.50 and $22.90, versus analysts’ estimate of $23.50.

“I am incredibly optimistic about the future of Ulta Beauty ( ULTA ), as I believe we have the right elements to drive our success – a strong business model, an ambitious long-term plan, and passionate associates who bring our brand to life for our guests every day. Fiscal 2025 will be a pivotal year as we make purposeful investments to fuel our future growth and move quickly to optimize our business. While it will take time to see the impact of these efforts, we are confident these investments will help reignite our momentum and unlock sustained growth and long-term value for our shareholders,” said Kecia Steelman, president and CEO of Ulta.

Analyst Changes: Following the earnings report, multiple analysts issued price target adjustments.

Morgan Stanley analyst Simeon Gutman maintained an Overweight rating on Ulta and lowered the price target from $500 to $460.

Telsey Advisory Group analyst Dana Telsey maintained an Outperform rating on Ulta and lowered the price target from $500 to $460.

Piper Sandler analyst Korinne Wolfmeyer maintained a Neutral rating on Ulta and lowered the price target from $425 to $364.

B of A Securities analyst Lorraine Hutchinson maintained a Neutral rating on Ulta and lowered the price target from $475 to $380.

See Also: Rubrik To Rally More Than 48%? Here Are 10 Top Analyst Forecasts For Friday

ULTA Price Action: At the time of writing, Ulta stock is trading 7.36% higher at $337.34, according to data from Benzinga Pro.

Image: via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tandem Diabetes Care Shares Rise After Q1 Net Loss Shrinks, Sales Rise; Q2, 2024 Sales Guidance Set
Tandem Diabetes Care Shares Rise After Q1 Net Loss Shrinks, Sales Rise; Q2, 2024 Sales Guidance Set
May 3, 2024
11:45 AM EDT, 05/03/2024 (MT Newswires) -- Tandem Diabetes Care ( TNDM ) shares surged nearly 22% in recent Friday trading, a day after the company reported Q1 sales that exceeded market expectations. The company reported Q1 net loss Thursday of $0.65 per diluted share, narrowing from $1.92 a year earlier. Analysts polled by Capital IQ expected a loss of...
RBC Reviews Trisura's Q1
RBC Reviews Trisura's Q1
May 3, 2024
11:38 AM EDT, 05/03/2024 (MT Newswires) -- Trisura ( TRRSF ) reported Q1/24 operating EPS of $0.68 vs. $0.57 in Q1/23, slightly ahead of RBC's $0.65 estimate and $0.66 consensus estimate. The modest upside was in both the Canada and U.S. segments. The Canadian unit delivered an impressive result in the quarter across the board with net written premium growth...
Why SaaS Company Conduent's Shares Are Surging Today
Why SaaS Company Conduent's Shares Are Surging Today
May 3, 2024
Conduent Inc ( CNDT ) shares are trading higher after the company signed an agreement to sell its Casualty Claims Solutions business to MedRisk. MedRisk is a managed care organization dedicated to the physical rehabilitation of workers’ compensation patients. The $240 million cash deal includes Conduent’s workers’ compensation and auto casualty bill review solutions. It also includes the processing of medical bills and clinical services, and its portfolio of Strataware bill review software products. In 2023,...
US fertilizer imports helping fund Russian war effort, CF Industries says
US fertilizer imports helping fund Russian war effort, CF Industries says
May 3, 2024
May 2 (Reuters) - U.S. agriculture companies have been brisk importers of Russian fertilizer since the 2022 Ukraine invasion, a practice that is unwittingly helping fund Russia's war against Ukraine, U.S. producer CF Industries ( CF ) said on Thursday. The U.S. does not impose sanctions directly on Russian fertilizer, which is important to global food supplies and prices. On...
Copyright 2023-2026 - www.financetom.com All Rights Reserved